✦ LIBER ✦

P1185 INTERIM SVR12 RESULTS FROM THE TELAPREVIR PHASE 3B REPLACE STUDY IN TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE 1 HCV INFECTION

✍ Scribed by Forns, X.; Samuel, D.; Mutimer, D.; Fagiouli, S.; Navasa, M.; Agarwal, K.; Berenguer, M.; Colombo, M.; Herzer, K.; Nevens, F.; Van Solingen-Ristea, R.; Luo, D.; Dierynck, I.; Witek, J.

Book ID: 122190323
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 91 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61345-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1186 TREATMENT-NAIVE STABLE LIVER TRANS

P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY

✍ Forns, X.; Samuel, D.; Mutimer, D.; Fagiouli, S.; Navasa, M.; Agarwal, K.; Beren 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 138 KB

P1123 RESPONSE-GUIDED THERAPY WITH BOCEP

P1123 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS INFECTED WITH HCV GENOTYPE 1: INTERIM RESULTS FROM THE TriCo STUDY

✍ Ferenci, P.; Flisiak, R.; Caruntu, F.A.; Lengyel, G.; Hohmann, M.; Bakalos, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB